A multivariate analysis identified the serum levels of DCP, creatinine, and LDH and positivity for the HBc antibody as independent prognostic factors among patients with TNM stage IV NAFLD-HCC (Table 3). The gene discussed is KRT88P; the disease is metabolic dysfunction-associated steatotic liver disease.